DYNLL1 antibody has been tested by ELISA, Western blot analysis and ICC/IF to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results.

Immunogen

Anti-human DYNLL1 mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human DYNLL1 protein 1-89 amino acids purified from E. coli.

Host

Mouse

Clonality

Monoclonal

Clone ID

PAT13C9AT

Isotype

IgG2b

Conjugate

Unconjugated

Purity

DYNLL1 antibody was purified from mouse ascitic fluids by protein-A affinity chromatography.

Product Form

Sterile filtered colorless solution.

Formulation

1mg/ml containing PBS, pH-7.4, 10% Glycerol and 0.02% Sodium Azide.

Synonyms

8 kDa dynein light chain, 8kDLC, Cytoplasmic dynein light polypeptide, DLC1, DLC8, DNCL1, DNCLC1, DYL1_HUMAN, Dynein , cytoplasmic, light chain 1, Dynein light chain 1 cytoplasmic, Dynein light chain 1, cytoplasmic, Dynein light chain LC8 type 1, Dynein light chain LC8-type 1, Dynein, cytoplasmic, light polypeptide 1, Dynein, light chain, LC8-type 1, HDLC1, LC8, LC8a, MGC126137, MGC126138, MGC72986, PIN, Protein inhibitor of neuronal nitric oxide synthase, Protein inhibitor of neuronal NOS

Isotype Controls

Suitable Secondaries

See all Anti-Mouse IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Publishing research using Anti-DYNLL1 Antibody [PAT13C9AT] (A58405)? Please let us know so that we can list the citation on this page.